“During the last years the development of approaches to multitarget drug design and discovery is gaining acceptance. The cannabinoids are potentially excellent multi-target drug candidates because of their interesting pharmacological profiles, among which stands out the dual capacity of cannabinoid ligands to act as cannabinoid agonist and cholinesterase inhibitors.”

http://www.ncbi.nlm.nih.gov/pubmed/23369066

http://www.thctotalhealthcare.com/category/alzheimers-disease-ad/